In summary, we showed that activated SUMOylation restricted the cytokine-dependent induction of MHC-I and identified an additional SUMO-mediated mechanism regulating basal repression of the MHC-I/APM pathway in cancer. This evidence concerns the gene ANPEP and cancer.